Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003068329 | SCV003451264 | likely benign | not provided | 2024-09-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004070329 | SCV003878853 | uncertain significance | not specified | 2023-02-16 | criteria provided, single submitter | clinical testing | The c.248C>T (p.A83V) alteration is located in exon 4 (coding exon 4) of the DNAJC17 gene. This alteration results from a C to T substitution at nucleotide position 248, causing the alanine (A) at amino acid position 83 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |